Latest Alkaloids Stories
CALGARY, Nov. 29 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
SEATTLE, Nov. 18 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today reported updated results from a Phase 1 clinical trial of PX-866, an irreversible small molecule phosphatidylinositol-3-kinase (PI-3K) inhibitor, in patients with advanced solid tumors.
New findings released today help identify the long-term impact of the prenatal environment and early parental care on the brain.
SEATTLE, Nov. 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chemotherapeutic agent docetaxel.
DALLAS and NEW YORK, Nov. 3, 2010 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.
A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.
BRIDGEWATER, N.J., Oct. 1 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S.
MIT researchers and collaborators from Tufts University have now engineered E. coli bacteria to produce large quantities of a critical compound that is a precursor to the cancer drug Taxol, originally isolated from the bark of the Pacific yew tree.
BURLINGTON, Mass., Sept.
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.